Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41 | $35 | $29 | $35 |
| Short-Term Investments | $0 | $97 | $71 | $87 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $87 | $7 | $5 | $5 |
| Total Curr. Assets | $128 | $140 | $105 | $126 |
| Property Plant & Equip (Net) | $9 | $10 | $10 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $23 | $7 | $7 |
| Tax Assets | $0 | $0 | $0 | $3 |
| Other NC Assets | $7 | $3 | $3 | $0 |
| Total NC Assets | $16 | $36 | $20 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $144 | $176 | $126 | $147 |
| Liabilities | – | – | – | – |
| Payables | $5 | $20 | $12 | $6 |
| Short-Term Debt | $3 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $2 | $2 | $5 |
| Total Curr. Liab. | $17 | $32 | $31 | $23 |
| LT Debt | $6 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $6 | $7 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $9 | $9 | $10 |
| Total Liabilities | $23 | $38 | $38 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$359 | -$339 | -$313 | -$280 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $480 | $0 | $0 | $0 |
| Total Equity | $121 | $138 | $88 | $117 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $144 | $176 | $126 | $147 |
| Net Debt | -$33 | -$35 | -$29 | -$35 |